(E)-3-[4-(3-METHYLBUT-2-ENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
Compound with spectra: 1 NMR
![(E)-3-[4-(3-METHYLBUT-2-ENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE](/api/compound/4WNdea53P8U.png?ph=true&h=300&w=458 "(E)-3-[4-(3-METHYLBUT-2-ENYLOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE")
| SpectraBase Compound ID | 4WNdea53P8U |
|---|---|
| InChI | InChI=1S/C22H20N4O/c1-16(2)13-14-27-19-10-7-17(8-11-19)9-12-21-24-25-22-20-6-4-3-5-18(20)15-23-26(21)22/h3-13,15H,14H2,1-2H3/b12-9+ |
| InChIKey | VFGQUUPNQFRWHZ-FMIVXFBMSA-N |
| Mol Weight | 356.43 g/mol |
| Molecular Formula | C22H20N4O |
| Exact Mass | 356.163711 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(E)-3-(4-ETHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-(4-METHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-(4-(2',2',2'-TRIFLUOROETHOXY)-STYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
(E)-3-(4-TRIFLUOROMETHOXYSTYRYL)-[1.2.4]-TRIAZOLO-[3.4-ALPHA]-PHTHALAZINE
3-(Pyrrolidin-1'-yl)-(1,2,4)-triazolo[3,4-a]phthalazine
5-(2-chlorophenyl)-4-{[(E)-(2,4,5-trimethoxyphenyl)methylidene]amino}-4H-1,2,4-triazol-3-yl hydrosulfide
4-{[(E)-(2,3-dimethoxyphenyl)methylidene]amino}-5-(2-methoxyphenyl)-4H-1,2,4-triazole-3-thiol
5-(diethylamino)-2-((E)-{[3-(2-methoxyphenyl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]imino}methyl)phenol
4-{[(E)-(2,5-dimethoxyphenyl)methylidene]amino}-5-(2-methoxyphenyl)-4H-1,2,4-triazole-3-thiol
4-{[(E)-9-anthrylmethylidene]amino}-5-(2-chlorophenyl)-4H-1,2,4-triazole-3-thiol
| Title | Journal or Book | Year |
|---|---|---|
| Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents | Journal of Medicinal Chemistry | 2011 |